Brokerages Set Cooper Companies Inc (COO) PT at $259.70

Cooper Companies Inc (NYSE:COO) has been assigned a consensus recommendation of “Buy” from the fourteen analysts that are presently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $259.70.

COO has been the topic of a number of recent analyst reports. Stifel Nicolaus raised their target price on shares of Cooper Companies from $265.00 to $275.00 and gave the stock a “buy” rating in a research report on Tuesday, September 12th. J P Morgan Chase & Co reaffirmed a “hold” rating and set a $235.00 target price on shares of Cooper Companies in a research report on Tuesday, September 12th. Robert W. Baird reaffirmed a “buy” rating and set a $273.00 target price (up from $267.00) on shares of Cooper Companies in a research report on Tuesday, September 12th. Oppenheimer reiterated a “hold” rating and set a $250.00 price objective on shares of Cooper Companies in a research note on Tuesday, September 12th. Finally, Stephens reiterated an “equal weight” rating and set a $250.00 price objective (up from $235.00) on shares of Cooper Companies in a research note on Tuesday, September 12th.

Institutional investors and hedge funds have recently made changes to their positions in the business. ProVise Management Group LLC lifted its stake in shares of Cooper Companies by 0.6% during the second quarter. ProVise Management Group LLC now owns 1,177 shares of the medical device company’s stock worth $282,000 after buying an additional 7 shares during the period. YorkBridge Wealth Partners LLC lifted its stake in shares of Cooper Companies by 2.1% during the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after buying an additional 11 shares during the period. Wedbush Securities Inc. lifted its stake in shares of Cooper Companies by 1.0% during the second quarter. Wedbush Securities Inc. now owns 1,783 shares of the medical device company’s stock worth $427,000 after buying an additional 18 shares during the period. Sentry Investment Management LLC lifted its stake in shares of Cooper Companies by 0.7% during the second quarter. Sentry Investment Management LLC now owns 2,801 shares of the medical device company’s stock worth $671,000 after buying an additional 19 shares during the period. Finally, Suntrust Banks Inc. lifted its stake in shares of Cooper Companies by 0.6% during the second quarter. Suntrust Banks Inc. now owns 6,616 shares of the medical device company’s stock worth $1,583,000 after buying an additional 40 shares during the period. Institutional investors own 96.79% of the company’s stock.

Cooper Companies (COO) traded down $5.24 during trading on Friday, reaching $224.06. 629,246 shares of the company were exchanged, compared to its average volume of 432,936. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.41 and a quick ratio of 1.26. Cooper Companies has a 12 month low of $172.83 and a 12 month high of $256.39. The stock has a market cap of $11,224.01, a price-to-earnings ratio of 23.59, a P/E/G ratio of 1.85 and a beta of 0.54.

Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.64 by $0.01. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The company had revenue of $561.50 million for the quarter, compared to analyst estimates of $558.86 million. During the same period in the prior year, the company posted $2.28 EPS. The firm’s revenue for the quarter was up 8.3% on a year-over-year basis. equities analysts predict that Cooper Companies will post 11.51 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This story was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this story can be read at https://sportsperspectives.com/2017/12/19/brokerages-set-cooper-companies-inc-coo-pt-at-259-70.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Analyst Recommendations for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply